These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38812565)

  • 1. Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9.
    Zhang JF; Shang K; Kim SW; Park JY; Wei B; Jang HK; Kang M; Cha SY
    Front Vet Sci; 2024; 11():1385958. PubMed ID: 38812565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus.
    Zhang JF; Park JY; Kim SW; Choi YR; Cha SY; Jang HK; Wei B; Kang M
    Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of A Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene Editing.
    Tang N; Zhang Y; Sadigh Y; Moffat K; Shen Z; Nair V; Yao Y
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32098149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of Chickens against H9N2 Avian Influenza Isolates with a Live Vector Vaccine Expressing Influenza Hemagglutinin Gene Derived from Y280 Avian Influenza Virus.
    Zhang JF; Kim SW; Shang K; Park JY; Choi YR; Jang HK; Wei B; Kang M; Cha SY
    Animals (Basel); 2024 Mar; 14(6):. PubMed ID: 38539970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age.
    Gelb J; Jackwood DJ; Brannick EM; Ladman BS
    Avian Dis; 2016 Sep; 60(3):603-12. PubMed ID: 27610719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel Insertion Site HVT-005/006 for the Generation of Recombinant Turkey Herpesvirus Vector.
    Zai X; Shi B; Shao H; Qian K; Ye J; Yao Y; Nair V; Qin A
    Front Microbiol; 2022; 13():886873. PubMed ID: 35694305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.
    Gao H; Cui H; Cui X; Shi X; Zhao Y; Zhao X; Quan Y; Yan S; Zeng W; Wang Y
    PLoS One; 2011; 6(7):e22549. PubMed ID: 21818336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
    Li Y; Reddy K; Reid SM; Cox WJ; Brown IH; Britton P; Nair V; Iqbal M
    Vaccine; 2011 Oct; 29(46):8257-66. PubMed ID: 21907750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and immune efficacy of a recombinant turkey herpesvirus vaccine strain expressing fusion protein of genotype VII Newcastle disease virus.
    Jia W; Zhang X; Wang H; Teng Q; Xue J; Zhang G
    Vet Microbiol; 2022 May; 268():109429. PubMed ID: 35421830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Andoh K; Yamazaki K; Honda Y; Honda T
    Arch Virol; 2017 Apr; 162(4):931-941. PubMed ID: 27942974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Novel Infectious Clone of Recombinant Herpesvirus of Turkey Fc-126 Expressing VP2 of IBDV.
    Shah AU; Wang Z; Zheng Y; Guo R; Chen S; Xu M; Zhang C; Liu Y; Wang J
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Turkey Herpesvirus Expressing H9N2 HA Gene at the HVT005/006 Site Induces Better Protection Than That at the HVT029/031 Site.
    Zai X; Shi B; Shao H; Qian K; Ye J; Yao Y; Nair V; Qin A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
    Cui H; Gao H; Cui X; Zhao Y; Shi X; Li Q; Yan S; Gao M; Wang M; Liu C; Wang Y
    PLoS One; 2013; 8(1):e53340. PubMed ID: 23301062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector.
    Iqbal M
    Bioengineered; 2012; 3(4):222-6. PubMed ID: 22705840
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sadigh Y; Powers C; Spiro S; Pedrera M; Broadbent A; Nair V
    NPJ Vaccines; 2018; 3():21. PubMed ID: 29872549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a recombinant turkey herpesvirus (H9) vaccine against H9N2 avian influenza virus in chickens with maternal-derived antibodies.
    Pan X; Liu Q; Niu S; Huang D; Yan D; Teng Q; Li X; Beerens N; Forlenza M; de Jong MCM; Li Z
    Front Microbiol; 2022; 13():1107975. PubMed ID: 36777028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of HDR-CRISPR/Cas9 and Erythrocyte Binding for Rapid Generation of Recombinant Turkey Herpesvirus-Vectored Avian Influenza Virus Vaccines.
    Chang P; Ameen F; Sealy JE; Sadeyen JR; Bhat S; Li Y; Iqbal M
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31766655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.